Deborah Matzura‐Wolfe

Author

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

D Matzura-Wolfe, D. Matzura-Wolfe, D.M. Matzura-Wolfe, Deborah Matzura-Wolfe, Deborah Matzura‐Wolfe

Publications

463

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Henry Ford Hospital Duke University St. Luke's Hospital University of California, Irvine

About

Deborah Matzura‐Wolfe is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacotherapy, medicine, and psychopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	135
2	Psychiatry	1	1	117
3	Mental Health	1	1	117
4	Psychopathology	1	1	117
5	Psychotherapy	1	1	117

Deborah Matzura‐Wolfe

Publications

457

Citations

H-Index

Page 1

	Year	Citations
A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks Mark S. Kramer, Deborah Matzura‐Wolfe, A. Polis, Neurology	1998	147
A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder Mark S. Kramer, Neal R. Cutler, James C. Ballenger, Biological Psychiatry Experimental PsychopathologyPsychiatryMedicinePsychotropic MedicationCckb Antagonist	1995	117
Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials W. Joseph Herring, Kathleen M. Connor, Ellen Snyder, Journal of Clinical Sleep Medicine	2016	77
Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials W. Joseph Herring, Ellen Snyder, Jill Hutzelmann, American Journal of Geriatric Psychiatry	2017	70
Pharmacokinetics of Rizatriptan Tablets During and Between Migraine Attacks Neal R. Cutler, Stanford S. Jhee, Anup Majumdar, Headache The Journal of Head and Face Pain	1999	28
Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data W. Joseph Herring, Kathryn M. Connor, Ellen Snyder, Psychopharmacology Pooled Phase-3 DataSleep DisordersSleepSleep DisorderPharmacotherapy	2017	18

Page 1